OptiScanner 5000 Cleared in U.S. for Continuous Glucose Monitoring in ICU
OptiScan Biomedical, a company based in Hayward, California, won FDA clearance to introduce its OptiScanner 5000 in the U.S. The device is intended for use in intensive care units to continuously monitor blood plasma glucose levels, something the Opt...
Source: Medgadget - Category: Medical Devices Authors: Editors Tags: Anesthesiology Cardiology Critical Care Emergency Medicine Neurology Neurosurgery Pediatrics Source Type: blogs
More News: Anesthesia | Anesthesiology | Brain | Cardiology | Clinical Trials | Emergency Medicine | Heart | Intensive Care | Medical Devices | Neurology | Neurosurgery | Pediatrics | Study